0XUW47Z
Supplement Little Finger, Left to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | X Anatomical Regions, Upper Extremities |
| Operation | U Supplement |
| Body Part | W Little Finger, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures put in biological or synthetic material to reinforce or augment an upper extremity structure that remains in place, rather than replacing it outright. A typical scenario is applying a mesh or patch graft over an area of weakened soft tissue or fascia in the arm to strengthen it, or augmenting a regional defect with additional material while the native anatomy stays where it is.
This approach is chosen when the existing tissue is intact enough to remain functional but needs added support, commonly after trauma, chronic strain, or a structural weakness identified during another procedure. It differs from a from-scratch repair because material is physically added to bolster the area, and it differs from a full swap because nothing is being removed and replaced.
Anatomy & Axis Detail
Little Finger, Left
For the left little finger, Supplement reinforces ligamentous or capsular structures, most often the ulnar collateral ligament or volar plate of the metacarpophalangeal or proximal interphalangeal joint, addressing chronic laxity that undermines the hand's ulnar border stability during grip. As the outermost digit with no adjacent finger to share load on its ulnar side, the little finger depends heavily on its own ligamentous integrity, so augmentation with graft or synthetic material is placed to restore resistance to angular stress without removing the native structure. The digit's reduced soft tissue bulk compared to central fingers can influence graft choice and fixation. Precise documentation of the joint level, structure augmented, and material type supports correct coding and distinguishes the procedure from repair of an acutely torn ligament.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign a code from this family when the operative note documents that graft, mesh, or synthetic material was placed onto or into an existing upper extremity structure purely to reinforce or augment it, with the native tissue left intact, and the documentation should specify the material type and the exact regional location covered. A common error is coding Supplement when the surgeon actually excised damaged tissue first and put in a substitute, which belongs under Replacement instead. Another recurring issue is failing to capture whether the reinforcing material is autologous, nonautologous, or synthetic, since this qualifier changes the specific code and is easy to overlook if the operative note only says "graft placed" without further detail.